Armata Pharmaceuticals (ARMP) Current Assets (2013 - 2026)
Armata Pharmaceuticals (ARMP) posted Current Assets of $5.9 million for Q1 2026, down 44.26% sequentially from $10.7 million in Q4 2025, and down 54.84% YoY from $13.2 million in Q1 2025.
Armata Pharmaceuticals (ARMP) Current Assets (2013 - 2026) Analysis & Trends
Armata Pharmaceuticals has reported Current Assets for 14 years, with the latest figure at $5.9 million in Q1 2026.
- Quarterly Current Assets fell 54.84% year-over-year to $5.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $5.9 million (down 54.84% YoY) and the FY2025 annual result came in at $10.7 million, down 5.66% from the prior year.
- Current Assets retreated to $5.9 million in Q1 2026 per ARMP's latest filing, from $10.7 million in the prior quarter.
- Over five years, Current Assets peaked at $48.7 million in Q1 2022 and troughed at $5.9 million in Q1 2026.
- A 5-year average of $25.4 million and a median of $26.8 million in 2023 frame the typical range for Current Assets.
- The sharpest annual moves came in 2022 and 2025: Current Assets jumped 134.48% in 2022, then plunged 75.67% in 2025.
- Over 5 years, Current Assets stood at $27.0 million in 2022, then declined by 29.19% to $19.2 million in 2023, then tumbled by 40.95% to $11.3 million in 2024, then decreased by 5.66% to $10.7 million in 2025, then tumbled by 44.26% to $5.9 million in 2026.
- According to Business Quant data, Current Assets over the past three periods registered $5.9 million, $10.7 million, and $16.9 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 12.54 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 18.45 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 8.07 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 5.82 Bn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 7.22 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 4.62 Bn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 1.63 Bn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 1.76 Bn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 18.80 Bn |
| 10 | Armata Pharmaceuticals | 162.98 Mn | 138.98 Mn | - | 27.16 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 27.16 Mn |
| Mar 31, 2026 | 5.95 Mn |
| Dec 31, 2025 | 10.67 Mn |
| Sep 30, 2025 | 16.93 Mn |
| Jun 30, 2025 | 7.52 Mn |
| Mar 31, 2025 | 13.17 Mn |
| Dec 31, 2024 | 11.31 Mn |
| Sep 30, 2024 | 22.39 Mn |
| Jun 30, 2024 | 30.90 Mn |
| Mar 31, 2024 | 41.72 Mn |
| Dec 31, 2023 | 19.15 Mn |
| Sep 30, 2023 | 36.59 Mn |
| Jun 30, 2023 | 26.83 Mn |
| Mar 31, 2023 | 38.60 Mn |
| Dec 31, 2022 | 27.05 Mn |
| Sep 30, 2022 | 33.25 Mn |
| Jun 30, 2022 | 41.31 Mn |
| Mar 31, 2022 | 48.70 Mn |
| Dec 31, 2021 | 15.00 Mn |
| Sep 30, 2021 | 14.18 Mn |